Search

You searched for "email"

1538 results found

Moorfields: The 2025 macula course

2 June 2025 -5 June 2025
The 2025 Macula course will take place from 2nd - 5th June 2025. Bookings are now open. Retinal diseases are a major cause of blindness. Diagnostic investigations, understanding of disease mechanisms, new therapies, and the evidence base, have all evolved...

The curse of the college museum

4 December 2024 | | EYE - General
David Greig lecture notebook. Courtesy of Dr Jacqueline Cahif, College Archivist, Royal College of Surgeons of Edinburgh. As sure as the inevitability of death and taxes, the hidden stories of past events will intermittently rise to the surface like oil...

Here comes the fear

2 June 2025 | | EYE - General
“At a cardiac arrest, the first procedure is to take your own pulse” The quote above is the Fat Man’s third law from the book The House of God by Samuel Shem, previously described in the ‘Doctor by the sea’...

Ophthalmic entrepreneurship: Reflections from an ophthalmic surgeon

3 June 2026 | | EYE - General
For many ophthalmic trainees and newly appointed consultants, the idea of medical entrepreneurship can feel distant and sometimes uncomfortable. We are trained in a profession centred on patient care, ethics and service. The word entrepreneur, by contrast, often brings to...

Part 3: The Arclight Project: Implementation workshops

2 August 2024 | | EYE - General
In this three-part series (Click here for Part 1 and Part 2) Andrew Blaikie and his team explore the role and application of the Arclight Device in Imaging of the Eye. The Arclight Project aims to support and enhance the...

Quantum imaging research could improve retinal scans

28 October 2025 | OCT, Imaging, Diagnosis, research, Retina
New EU-funded feasibility project is testing a quantum approach that could reveal finer detail in the eye than ever before. A European research consortium is exploring a new quantum imaging technique that could one day help clinicians see the earliest...

Landmark dataset to accelerate research on anterior segment eye disease

1 July 2026 | research, technology, diagnostics
Diseases affecting the anterior segment, the front part of the eye, are among the leading causes of visual impairment and blindness globally, yet few large-scale datasets have been available for these conditions. In response, clinical researchers at Moorfields Eye Hospital...

Ciliatech reports positive clinical results on novel glaucoma implant, CID, in 24-month post-operative follow up

29 March 2023 | glaucoma
Chavanod (near Annecy), France, March 29, 2023 - Ciliatech, an ophthalmology medtech company developing a new class of implant to treat glaucoma durably, announced the positive results of a 24-month post-operative follow-up on a clinical trial of CID, its first generation Cilio-scleral Inter-positioning Device.

Cabinet Secretary backs call for major shift in venue accessibility

18 September 2025 | The Culture Section, music, art, accessibility, UK
Scotland’s Culture Secretary Angus Robertson has thrown his support behind Sight Scotland’s Accessible Venues Campaign, which aims to make every theatre, concert hall and cultural venue fully accessible for people with vision impairment. Mr Robertson recently met with members of...

The results of the last survey Oct20

5 October 2020 | | EYE - Glaucoma, EYE - Cataract, EYE - Refractive, EYE - General
The point of this series is to find variations in practice and to raise them to you, the readership, so you can review and reflect upon them. I am aware there is not always a ‘correct’ way of doing things,...

BCPB chair takes on Everest challenge

1 May 2020
BCPB's Chair, Paul Hunter is climbing Mount Everest at home via his stairs during lock down to raise vital funds for the charity's blindness prevention work.

Our 100% Optical / Ophthalmology 'Photo Dump'

3 March 2025
Here it is: the gallery you never knew you needed. We've curated a small selection of images for you that we've collected during our time at 100% Optical / Ophthalmology this past weekend. If you haven't been receiving our day-to-day...